Related Experiment Videos
Clinical experience with incidentally discovered pheochromocytoma
A Miyajima1, J Nakashima, S Baba
1Department of Urology, Keio University School of Medicine, Shinjuku, Tokyo, Japan.
The Journal of Urology
|May 1, 1997
Summary
Incidental pheochromocytomas often present with weaker symptoms and lower urinary catecholamines but are larger. Despite these differences, surgical risks are similar to symptomatic pheochromocytomas.
Area of Science:
- Endocrinology
- Oncology
- Surgical Pathology
Background:
- Pheochromocytomas are rare neuroendocrine tumors.
- Distinguishing between symptomatic and incidentally discovered pheochromocytomas is crucial for management.
Purpose of the Study:
- To compare clinical, biochemical, and imaging features of symptomatic versus incidentally discovered pheochromocytomas.
- To investigate the characteristics of incidentally discovered pheochromocytomas.
Main Methods:
- Retrospective review of 17 resected pheochromocytomas.
- Comparison of patient demographics, symptoms, tumor characteristics, and diagnostic test results.
- Evaluation of urinary catecholamine levels and metoclopramide stimulation tests.
Main Results:
- Incidental pheochromocytomas showed lower urinary dopamine and tended to have lower noradrenaline and vanillylmandelic acid levels.
- Despite weaker symptoms, incidental tumors were significantly larger on average.
- The metoclopramide stimulation test had a high false-negative rate (71%) in incidental cases.
Conclusions:
- Incidental pheochromocytomas may present with subtle clinical signs and lower catecholamine levels but are often larger.
- Surgical risk for incidental pheochromocytomas is comparable to symptomatic ones.
- Appropriate surgical management should be considered for all incidentally discovered pheochromocytomas.